JITC

Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study
Yu-Qi Wang, Wen-Jin Chen, Wang Zhou, Ke-Qin Dong, Li Zuo, Da Xu, Jia-Xin Chen, Wei-Jie Chen, Wen-Yan Li, Zi-Chang Liu, Zheng-Yu Jiang, Yi-Fan Tang, Yu-Xuan Qin, Lin-Hui Wang, Xiu-Wu Pan, Xin-Gang Cui

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008613; DOI: 10.1136/jitc-2023-008613
Protein O-fucosyltransferase 1 promotes PD-L1 stability to drive immune evasion and directs liver cancer to immunotherapy
Qianyu Li, Wenyun Guo, Yifei Qian, Songling Li, Linfeng Li, Zijun Zhu, Fan Wang, Yu Tong, Qiang Xia, Yanfeng Liu

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008917; DOI: 10.1136/jitc-2024-008917
Complex immune microenvironment of chordoma: a road map for future treatment
Hua-Qing Niu, Bo-Yv Zheng, Ming-Xiang Zou, Bo-Wen Zheng

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e009313; DOI: 10.1136/jitc-2024-009313
Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma
Lianjun Zhao, Yu Ren, Guiying Zhang, Kelin Zheng, Jiayu Wang, Huizi Sha, Mengke Zhao, Rong Huang, Donglin Kang, Xinyu Su, Yirong Wu, Wangling Zhang, Ruihe Lai, Lin Li, Rui Mei, Yitao Wang, You Tian, Fufeng Wang, Baorui Liu, Zhengyun Zou

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008611; DOI: 10.1136/jitc-2023-008611
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision
Leisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, Tullia C Bruno, Christian M Capitini, Deborah Collyar, James L Gulley, Patrick Hwu, Avery D Posey, Ann W Silk, Jennifer A Wargo

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e009063; DOI: 10.1136/jitc-2024-009063
Perspectives from the leadership of Journal for ImmunoTherapy of Cancer
Sjoerd H van der Burg, Michael T Lotze

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e009661; DOI: 10.1136/jitc-2024-009661
Hypothesis: AdAPT-001 and pseudoprogression – when seeing is not necessarily believing
Anthony Conley, Christopher Larson, Bryan Oronsky, Meaghan Stirn, Scott Caroen, Tony R Reid

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008809; DOI: 10.1136/jitc-2024-008809
Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by ¹⁸F-BMS-986192 PET: pooled analysis of data from four solid tumor types
Iris H C Miedema, Johanna E. E. Pouw, Anne Kwakman, Gerben J C Zwezerijnen, Marc C Huisman, Florentine E F Timmer, Rieneke van de Ven, Tanja D de Gruijl, Geke A P Hospers, Adrianus J de Langen, C Willemien Menke-van der Houven van Oordt

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008899; DOI: 10.1136/jitc-2024-008899
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion
Yuanyuan Chen, Dijun Ouyang, Yan Wang, Qiuzhong Pan, Jingjing Zhao, Hao Chen, Xinyi Yang, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Jin-Qi You, Yingzi Li, Chi Xu, Yan Ren, Sisi Xie, Song Li, Jiamin Lian, Desheng Weng, Tong Xiang, Jian-Chuan Xia

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008375; DOI: 10.1136/jitc-2023-008375
Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer
Sofie Traynor, Mie K Jakobsen, Tina M Green, Hana Komic, Yaseelan Palarasah, Christina B Pedersen, Henrik J Ditzel, Fredrik B Thoren, Per Guldberg, Morten F Gjerstorff

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008759; DOI: 10.1136/jitc-2023-008759

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages